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ABSTRACT
Evaluation of an Intra-Operative 1-125 Brachytherapy Implant Technique
by
Tserenpagma Chaoui
Dr. Phillip Patton, Examination Committee Chair 
Assistant Professor o f Health Physics 
University o f Nevada, Las Vegas
The purpose o f this study was to evaluate the usefulness o f an intra-operative 
planning method in brachytherapy prostate seed placement by comparing pre-planning 
and intra-operative planning techniques. This comparison was achieved by a virtual- 
planning technique in which the pre-planned seed and needle positions are superimposed 
on the intra-operatively obtained volume study. Dosimetric evaluation of each implant 
was based on the dose volume histogram (DVH) generated from CT studies and analysis 
o f image and seed numbers, target volume and inferior extent o f posterior planes. These 
parameters showed that greater dosimetric values are noted in the intra-operative 
technique. The study demonstrated a benefit from an intra-operative approach to seed 
placement as opposed to a pre-planned approach. Defining the sagittal contours o f the 
prostate, immediately prior to implant, reduced the inferior extent of seeds placed in the 
most posterior aspect o f the prostate, thereby decreasing the probability for rectal 
complication and morbidity. Additionally, more correctly delineating the tranverse
111
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prostate contours at the time of seed placement resulted in fewer seeds placed in the 
periprostatic region, outside the PTV, thus reducing potential seed migration and 
increasing prostate dose coverage.
IV
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CH APTER 1
IN TRO D U CTIO N  
IT  Background
Brachytherapy is a radiotherapeutic technique that places radioaetive isotopes within 
body cavities or directly into a tissue region with a goal of delivering a high dose to the 
region while sparing the normal surrounding tissue. When radium was discovered by the 
Curies in 1898, it became the most commonly used isotope for brachytherapy because o f 
its long half life (1,600 years) and high photon energy (0.83 MeV average). However, the 
handling of this isotope involved substantial risks of radiation exposure to the physician 
and supporting personnel. Therefore, a number of artificially produced radioisotopes 
were introduced, such as Ir-192, Au-198, Cs-137, 1-125 and Pd-103. These isotopes have 
lower photon energies with much shorter half-lives than radium; thus, decreasing the 
radiation hazards associated with the procedures.
1.2 Brachytherapy Techniques 
In brachytherapy, there are three major treatment techniques: surface molds, 
interstitial therapy, and intracavitary therapy. Surface molds are used to treat small 
superficial areas. The sources are carefully placed on the outer surface of the mold. The 
distance between the source and skin surface is between 0.5 and 1.0 cm. In intracavitary
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
techniques, an applicator is inserted into a body cavity to reach the tumor. Intracavitary 
treatments are used primarily for cancers of the uterine cervix, uterine body and vagina 
(Khan M, 2003).
Interstitial brachytherapy is a very complex technique with implantation occurring in 
a surgical room while the patient is under anesthesia or sedation. Interstitial catheters are 
inserted directly into the tumor through the body tissue. In the case o f prostate and 
gynecologic cases, a rubber template is sutured to the outside skin to hold the treatment 
catheters in position. Interstitial implants may be permanent or temporary. In temporary 
implants, the sources are removed after the prescribed dose has been delivered. 
Palladium-103 or 1-125 is commonly used in permanent implants. Both temporary and 
permanent interstitial implants might use afterloading techniques. The significance o f 
afterloading techniques is to reduce radiation exposure to personnel and to eliminate the 
direct handling o f the radioactive sources.
High dose rate (HDR) brachytherapy involves the temporary placement of a tiny 
radioactive source with high activity, on the order of curies, into a tumor through a 
eatheter to deliver a concentrated dose of radiation. After treatment, the radioactive 
source retracts into the afterloader. High dose rate remote afterloader treatment takes 
place in a fully shielded room with short treatment time. In Fig. 1, high dose rate remote 
afterloading implants achieve desired dose distributions by moving a single high strength 
Ir-192 source, connected to the end of a flexible cable, through one or more available 
channels (Khan, 2003). With the help of a computer-guided afterloader, the planning 
system calculates how long the radioactive source spends (dwell time) in specified 5 mm 
steps (dwell position) along the length of the catheter (Glen, 2003).
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Figure 1. HDR remote afterloading brachytherapy unit employs a miniature Iridium-192 
radioactive source at the end o f a steel wire to deliver the radiation treatment. The steel 
wire is under computer control. The position o f the source within the patient’s body and 
time length can he accurately controlled (www.tampabavprostateinstitute.com).
LDR brachytherapy occurs in the operating room, with the patient under spinal or 
general anesthesia. For prostate eancer, the delivery of radiation is targeted directly to the 
prostate gland through the implantation of small radioactive pellets. Needles are inserted 
through the skin o f the perineum. After each needle is in the proper position, the seeds are 
inserted according to the images seen on the ultrasound as shown in Fig. 2. These seeds 
emit radiation over several weeks or months, remaining in the prostate gland 
permanently. Most prostate implants require 60 to 120 seeds, depending on the size of the 
prostate.
The International Commission on Radiological Protection (ICRP) Report 38 
categorizes HDR as greater than 20 cGy per minute. Cancers such as breast, 
gynecological, and prostate cancers can be treated with HDR. Both HDR and LDR have 
the ability to deliver the radiation source to the tumor while sparing the normal tissues.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
The most important benefit o f HDR is the shorter treatment times when compared to 
LDR.
1
Figure 2. The physician pushes stainless steel needles through the pre-determined holes 
in the template, into the perineum and then the prostate, guided by the images seen on the 
ultrasound (www.tampabavprostateinstitute.com).
However, extra costs must be considered for room shielding and installing additional 
imaging equipment installation. Therefore, large number of brachytherapy treatments use 
LDR implants. The prescribed dose for these procedures is between 0.5 and 2.0 cGy per 
minute based upon size and type o f tumor (Nori et al. 1990). The types o f eancer treated 
with LDR brachytherapy are breast, head and neck, gynecologic, and prostate cancer. 
Even though LDR treatment is very common, it has some limitations. First, LDR 
treatment times are long. Any movement of the seed implant results in inadequate doses 
to the tumor and surrounding tissues. However, interstitial prostate brachytherapy with 
permanent seed implant is universally used because of its close proximity to the perineum 
(Sylvester et al. 1997).
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1.3 Prostate cancer
Prostate cancer is the most commonly diagnosed noncutaneous malignancy in the 
male population. In 1999, approximately 189,000 new case o f prostate cancer were 
diagnosed in the United States (Rietbergen et al. 1999). Prostate brachytherapy is one of 
the most improved treatments o f early prostate cancer treatment (S. Nag et al. 2001). In 
the last five to ten years, with the development of imaging modalities such as computed 
tomography (CT), and transrectal ultrasound (TRUS) together with template-based 
transperineal techniques, LDR brachytherapy results have shown an improved 
consistency in radiation dose delivery to the entire prostate.
In addition, prostate eancer can be detected by the prostate specific antigen (PSA) test 
at an early stage when no symptoms are present. PSA is a substance produced by cells 
from the prostate. Under normal circumstances, PSA is secreted by the prostate into 
semen to help with reproduction by preventing the eoagulation of semen. However, small 
amounts of PSA naturally leak into the bloodstream. When prostate cancer is present, the 
prostate ducts that normally secrete PSA into the urethra get clogged and more PSA leaks 
into the bloodstream. The PSA test can not confirm whether or not cancer is present, but 
it can suggest the need for further tests. By combining the patient’s PSA level with his 
Gleason score and the clinical stage estimated by the physician, it is possible to estimate 
the type of prostate cancer (Peter et al. 2005).
The Gleason score allows the doctors to understand how a particular case o f prostate 
cancer can be treated. In general, a physician gives a patient a combination o f two 
numbers. The lowest possible Gleason score is 2 (1+1), where both the primary and 
secondary patterns have a Gleason grade of 1. Dr. Gleason’s own simplified drawing of
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the five Gleason grades o f prostate cancer is illustrated in Fig 3. A very typical Gleason 
score might be between five to seven, and the highest possible Gleason score is ten. Dr 
Gleason discovered that by giving a combination o f the grades o f the two most common 
patterns he could see in any particular patient’s specimen, he was better able to predict 
whether the patient would respond positively by a particular treatment method 
(Tannenbaum M, 1977).
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Figure 3. This illustration shows Dr. Gleason’s own simplified drawing of the five 
Gleason grades for prostate cancer. Well differentiated Gleason grade 1 appears on the 
far left and poorly differentiated grade 5 on the far right. Adapted from Gleason DF. The 
Veteran’s Administration Cooperative Urologie Research Group: histologic grading and 
clinical staging of prostatic carcinoma. In Tannenbaum M (ed.) Urologie Pathology: The 
Prostate. Lea and Febiger, Philadelphia, 1977; 171-198.
In localized prostate cancer, the tumors are classified as T l, T2, T3 and T4 (Blank et 
al. 2000). T l lesions are clinically unapparent tumors. A prostate cancer stage T ic  is 
found as a consequence only of the patient having a positive PSA result with no other 
clinical sign of the disease. T2 is confined within the prostate. In cancer stage T3, the
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
tumor extends through the prostate capsule but has not spread to other organs. T4 on the 
other hand, is fixed or invades adjacent structures other than seminal vesicles.
Since the number o f patients having PSA tests increased rapidly in the past few years, 
stage Tic, T2a and T2b have become a relatively common diagnosed stage o f prostate 
cancer (Peter et al.2005). Radioactive seed implantation has rapidly become one o f the 
most popular treatment modalities of confined prostate cancer (Kaplan et al. 2000). 
Iodine-125 or Pd-103 seeds are commonly used in the treatment of early stage prostate 
cancer. The half-life of 1-125 (59.4 days) is long when compared to Rn-222 (3.83 days) 
and An-198 (2.7 days); thus it is very convenient for storage. Also, its low photon energy 
requires less shielding.
1.4 Treatment Planning System
In the 1980’s the modem technique o f seed implantation with 1-125 or Pd-103 seeds 
being inserted into the prostate gland with the guidance o f TRUS and a perineal template 
was developed. This procedure is nonsurgical and performed on an outpatient basis. The 
implant takes place in an operating room with the patient requiring a spinal anesthetic 
(Khan, 2003). A volume study is used to outline the loation and size of the prostate by a 
series of transverse ultrasound images shown in Fig 4. The patient is placed in the dorsal 
lithotomy position and the transrectal ultrasound prcobe is securely attached to obtain 
transverse images of the prostate gland from base to apex at 5-mm intervals. A grid is 
superimposed on each image as a coordinate system. The sagittal image is also obtained 
to measure the length o f the gland from the base to apex. Before the volume study, the 
prostate gland size and the pubic arch in relation to the prostate is determined by
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
computed tomography (CT) scans. If the pubic arch is too narrow it will prevent the 
needles from reaching the target. In the case o f a large gland with significant pubic arch 
interference, the patient may need hormonal therapy to reduce the size of the prostate. 
Hormonal therapy can cause a number o f unpleasant temporary side effects such as hot 
flashes, loss of libido, impotence and weight gain (Peter et al. 2005).
A treatment-planning system specifically designed for prostate gland implants allows 
the target outlines from the volume study to be digitized into the computer. The computer 
software allows the placement o f seeds on the template grid for each of the ultrasound 
images. Seed strength can be adjusted to deliver a prescribed minimum peripheral dose 
(MPD), which is the isodose surface just covering the prostate target volume.
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Figure 4. Ultrasound images are used to determine the size of the gland, and then to 
customize seed implant treatment (www.kcc.tiu.edu/RadOnc/brachy/hor.htm).
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Typical seed strengths are on the order o f 0.336 mCi for 1-125 (MPD=145 Gy) and 1.7 
mCi for Pd-103 (MPD=125 Gy) (Khan, 2003). The treatment-planning methods consist 
of pre-implant and/or intraoperative planning.
Preplanning is the creation o f a plan prior to implantation of the seeds. In most 
centers, prostate cancer is treated with an implant technique using only the preplanned 
dosimetry. However, this has three possible disadvantages. First, during the time between 
the preplan and the implant procedure, prostate volume and shape may change as a result 
of hormonal therapy or anesthesia. Secondly, the patient positioning, setup, and images 
acquired during the actual implant must be matched with those obtained during the pre­
implant plarming study. Third, in the pre-planned technique, a separate pubic arch 
evaluation study is required. The reason is that the pre-planned method requires a 
separate TRUS imaging planning study, which is awkward and sometimes difficult to 
schedule (Gewanter et al. 2000).
Intra-operative planning occurs in the operating room; the patient and TRUS probe 
stepper are not moved during the time between the volume study and seed insertion 
procedure. Treatment planning and the calculation of the dose distribution in real time is 
a new technique in the evolution o f prostate brachytherapy. Currently, there are two steps 
in the intraoperative planning: intraoperative preplanning and interactive planning. 
Intraoperative preplanning is the creation o f a plan in the operating room just before the 
implant procedure, with immediate execution of the plan. Meanwhile, TRUS is 
performed in the operating room, and the images are introduced in real time into the 
treatment planning system. The target volume, rectum, and urethra are contoured on the 
treatment planning system either manually or automatically. The treatment plan is created
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and the seeds are implanted into the prostate based upon this treatment plan (Nag et al 
2001). According to the Wilkinson et al. (2000), study, intraoperative pre-planning of 
prostate seed implants provides measurable improvements in dosimetric variables and 
greater patient comfort and convenience than the pre-planned techniques. However, 
intraoperative preplanning methods require additional operating room time and 
consequent costs. In general operating room time has decreased; therefore, the overall 
convenience of procedure without compromise of implant quality makes intraoperative 
preplanning the most suitable technique for TRUS-guided prostate brachytherapy 
(Gewanter et al. 2000).
Interactive planning is a stepwise improvement o f the treatment plan using 
computerized dose calculations derived from image-based needle position feedback. In 
the interactive planning, the process of seed ordering, image acquisition, target definition, 
and organ contouring is similar to the intraoperative preplanning method (Nag et al. 
2001). In other words, before the actual operative procedure, radioactive seeds are loaded 
into needles and a loading array is established with an autoradiograph. The prostate shape 
and urethra position are verified using ultrasound and a Mick applicator is used to 
implant seeds into the prostate (Fig. 5). Needle positioning is confirmed using transverse 
and sagittal ultrasound images along with fluoroscopy, with special attention to the 
bladder- prostate and rectal-prostate interfaces. The needles are repositioned or altered in 
the plan if there are adverse dosimetric consequences. The dose calculation is then 
updated based on actual needle location. The interval at which the dose distribution is 
recalculated is operator dependent. At the end of the procedure, the urologist performs 
cystoscopy to retrieve any lost seeds (Butler et al. 2000). In interactive planning the
10
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calculated dose distribution is based on implanted needle position; therefore, it is difficult 
to account for seed movement after deposition (Nag et al. 2000).
Figure 5. Cold needles are implanted prior to implanting the radioactive seeds, thus 
greatly avoiding radiation exposure to staff and personnel (www.micknuclear.com).
The evaluation of prostate brachytherapy implant treatment is hased on dosimetric 
measurements of CT or ultrasound images obtained after the actual implant procedure 
(Doggett. 1999). Post-operative dosimetry of CT images provides immediate feedback on 
each implant. Currently, the American Brachytherapy Society recommends the use o f 
CT-based, post-operative dosimetry on all patients (Nag et al.l999). The post-operative 
radiograph in Fig. 6 shows the radioaetive seed placement. The post-op dosimetry can 
then be calculated and compared to pre-planned dosimetry. Swelling of the prostate in the 
first two weeks makes it difficult to accurately define the gland and to calculate the 
resulting dose. As a result the CT study is usually performed four weeks post-operation 
(Doggett. 1999). Bice et al. (1998) have reported that the definition of prostate target
1 1
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volume on the post implant CT differed greatly between individual physicians. However, 
this diversity in target definition made very little difference in the calculated dose 
coverage o f the prostate gland. On average, C l 00, which is the percentage o f the prostate 
volume defined on post implant CT images that receives at least 100% of the prescription 
dose, was found to range from 79% to 96%. It was found that dosimetric coverage of the 
prostate improved with experience (Lee et al. 2000).
Since no optimal prostate implant teehnique has been defined, a number o f techniques 
have developed. Two of the main approaehes are (1) a pre planning technique where all 
calculations are made well ahead o f the implant date and (2) an intra-operative technique 
where seed positioning is determined at the time of the operative procedure. Both 
methods are designed to deliver higher doses to the target while sparing surrounding 
normal tissues (Matzkin et al. 2003).
Figure 6. Post-op radiograph of a prostate seed implant (www.proste-cancer.org)
12
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER 2
M ATERIA L AND M ETHODS
2.1 Patient Eligibility 
As can be seen in Table 1, forty-six patients between 52 and 83 years of age with 
early stage prostate cancer (T ic, T2a), Gleason scores less than or equal to 7 and PSA 
levels less than 11 ng/ml were chosen for this study. Thirteen percent of these patients 
had received pre-implant androgen ablation therapy. Exclusively, two radiation 
oncologists, utilizing an afterloading Mick applicator performed the prostate implant 
procedures. Iodine-125 seeds (Model 125SL) were obtained from Mentor Corp. (Santa 
Barbara, CA). Seed strengths ranged between 0.287 to 0.454 mCi in order to obtain the 
prescribed dose of 145 Gy for all forty-six patients. All patients were implanted using an 
interactive ultrasound guided transperineal technique. Evaluation of the intra-operative 
technique was made by comparison with an artificially created (virtual) technique in 
which the ‘preplanned’ needle and seed loading was superimposed on the prostate 
volume obtained at the time of the implant procedure.
2.2 Pre-planned Technique 
In the pre-planned technique, a volume study is obtained based upon initial transrectal 
ultrasound (TRUS) images acquired as much as three months prior to the actual implant 
procedure. This study is obtained in the office examining room with the patient unsedated
13
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and the legs placed in a dorsal lithotomy position. The initial volume study allows the 
physician to evaluate pubic arch interference and, if present, the size of any transurethral 
resection o f prostate (TURP) defects. Images of the prostate are obtained at 5 mm 
intervals. Using these contours a treatment plan is developed based upon the prescribed 
dose. This plan establishes a needle configuration and the appropriate number o f seeds to 
be ordered (based upon available source activity).
Table 1. Baseline Characteristics of the Patient Population (n=46)
Parameters Number (percent)
Age(years) 52-83
Activity(mCi) 0.287-0.454
Stage (Tlc-T2a) 46
PSA(ngZml)
0-4 5(10^^
4.1-9.9 39 (84.8)
10-11 2 (4.3)
Gleason Score
2-6 41 (89.1)
7 5(103%
Androgen ablation 6(I3(%
2.3 Intra-Operative Teehnique 
The patient is initially taken to the operating room and following induction of general 
anesthesia the legs are elevated to the dorsal lithotomy position. The ultrasound probe is 
placed into the rectum and the prostate is centered using the lateral and posterior aspects 
of the prostate with special attention to the spatial orientation of the urethra (visualized 
adequately with a foley catheter in place). A series of sagittal and axial orientations o f the 
prostate from base to apex are acquired at 5 mm intervals. These images are downloaded
14
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to the treatment-planning computer, where they are digitized and a revised seed 
placement plan is developed prior to the implant procedure. Intra-operative dosimetric 
calculations on the prostate volume, corrected for relaxation o f the patient following 
general anesthesia, are obtained. Due to the oblate spheroid shape of the prostate, an 
asymmetric margin is defined which varies from 2 to 5 mm in the anterior and lateral 
dimensions. From the apex through the mid portions of the prostate the margins are kept 
tight with more generous margins superiorly to allow for enhanced coverage o f the 
seminal vesicle region at the base o f the prostate. No posterior margin is defined over the 
entire prostate due to the close proximity of the rectum. These contoured margins define 
the planning target volume (PTV) and are devised and approved by the radiation 
oncologist. Efforts are made to place seeds within the capsule of the prostate although a 
limited number of extraprostatic seeds are used to achieve the desired PTV coverage 
described above. After-loading needles are then inserted through a transperineal template 
using coordinates derived from the ‘intra-operative’ plan. Planned seed positions can be 
manually modified to ‘real time’ positions based upon ultrasonic visualization.
2.4 Post Implants Dosimetry 
Dosimetric evaluation of each procedure is initially performed utilizing dose volume 
histograms (DVH) generated from pre-operative and pre-implant ultrasound images. Post 
implant dosimetric evaluation is performed on CT images obtained approximately three 
to four weeks following the implant procedure (CT images tend to overemphasize 
prostate volume compared to ultrasound). This time period allows for acute swelling o f 
the gland secondary to the implant procedure to subside. CT images of each slice are
15
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taken showing both soft tissue and bone densities. On each slice, the prostate volume, 
rectal and bladder wall, and urethra (if foley catheter is still in place) are outlined. 
Isodose curves and DVH values were generated. Additional prostate dosimetric 
parameters including D90 (maximum dose received by 90% o f the volume), V I00 
(volume receiving 100% of the prescribed dose), and V I50 (volume receiving 150% o f 
the prescribed dose) are obtained. Finally, a RlOO (rectal volume receiving 100% of the 
prescribed dose) is generated to assess implant design and quality o f  seed placement.
2.5 Investigation Method 
To evaluate the present intra-operative planning technique, a comparison was made 
with the pre-planned technique used by the radiation oncologist prior to obtaining the 
VariSeed Treatment Planning Software which permitted treatment planning in the 
operating room. This comparison was achieved by a virtual-planning technique in which 
the pre-planned seed and needle positions are superimposed on the intra-operatively 
obtained volume study. The superposition o f the pre-planned and intra-operative volume 
study is achieved by the alignment within the two studies of both the transverse images o f 
the prostate base and the sagittal images of the central prostate posterior margin. An 
investigation is then made o f the dosimetric differences obtained utilizing dosimetry 
parameters (D90, V I00, V I50, V200 and RlOO). Additionally, the number of slices, the 
number of seeds, and the inferior extent o f posterior planes are considered.
16
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER 3
RESULTS AND D ISCU SSIO N
3.1 Technique Comparison 
In order to evaluate the presently used intra-operative technique, comparison was 
made with a previously used pre-implant technique by creating an artificial virtual- 
technique. The virtual-technique superimposed seed and needle positions from the initial 
pre-implant volume study on the new volume study obtained at the time o f the implant. 
The average number of images and seeds together with the average prostate volume 
obtained from both transrectal ultrasound studies (TRUS) for forty-six patients are shown 
in Table 2. The average number of images for both techniques is the same (9 vs. 9). Also 
the average prostate volume for both techniques was within 1% (43.5 cc for pre-implant 
technique vs. 43.0 cc for intra-operative technique).
Table 2. Comparison of average number o f images, seeds and mean value of prostate 
volume between pre-implant and intra-operative techniques.
Technique Images Seeds Volume (cc)
Pre-implant 9±1 93±11.7 43.5±12.1
Intra-operative 9±1 92±12.4 43.0±13.0
17
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
The target volume for both techniques was an asymmetric volume consisting o f the 
prostate volume plus a margin varying from 2 to 5 mm in the anterior and lateral 
dimensions. Although the PTV differs for each implant procedure the average number of 
seeds placed within the gland differs by less than 1% between the intra-operative 
technique and the artificially created virtual-technique.
To evaluate the dosimetric differences between each technique, the number o f seeds 
outside the PTV, inferiorly and anteriorly or laterally, is determined from three- 
dimensional CT images. Table 3 shows the number of seeds outside the PTV, inferiorly 
and anteriorly or laterally, determined from three-dimensional CT images. In the intra­
operative technique only three patients had seeds implanted outside the PTV (inferiorly 
one had a single seed and a second had two seeds, laterally one had six seeds).
Table 3. Comparison between the two techniques of the number of seeds located 
inferiorly or anteriorly/laterally outside the PTV.
Parameters
Number of Patients in 
the Intra-operative 
Technique (n=46)
Number of Patients 
in the Virtual 
Technique (n=46)
Seeds outside PTV :
Inferior: 0-4 44(0), 2(1-2) 21
5-10 0 II
>11 0 14
Anterior or Lateral: 0-4 45 15
5-10 1 16
>11 0 15
In the virtual-technique, on the other hand, extreme cases are seen, 11 or more seeds 
were found outside the PTV (inferiorly in fourteen patients and anteriorly or laterally in 
fifteen patients) indicating a decrease in dose coverage and possible rectal complication
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leading to rectal morbidity if the pre-planning technique were implemented without any 
adaptation.
3.2 Dose Response
The dosimetric data D90 (maximum dose received by 90% of the volume), V I00 
(volume receiving 100% of the prescribed dose), V I50 (volume receiving 150% of the 
prescribed dose), and V200 (volume receiving 200% of the prescribed dose) for all forty- 
six patients o f both techniques are shown in Table 4. The average values, shown in Table 
5 for V200 (24.8±2.78% vs. 19.2±2.42%), V150 (58.3±3.74% vs. 47.9±4.16%) and VlOO 
(99.7±0.38% vs. 94.1±4.41) were greater by 29%, 22%, and 6% respectively for the 
intra-operative techniques. As well, the mean D90 values were higher (174.9±4.5Gy 
vs.l57.6±14.4Gy) for intra-operative cases compared to virtual-technique. In addition. 
Tables 3 and 5 indicate the strong correlation between dosimetric values and the number 
of seeds outside the PTV in the virtual-technique providing support for the use o f an 
intra-operative technique.
In a recent report, the Wilkinson et al. (2000) study showed the comparison of intra­
operative and pre-planning techniques. Even though their dosimetric evaluation was 
based on earlier (2000) CT studies. Table 6 shows the average value of VlOO (intra­
operative) was similar to our data shown in Table 5. In our study the average value o f 
both V I50 and D90, obtained intra-operatively, was greater than the Wilkinson et al. 
study by 260% and 28% respectively.
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Table 4. Dosimetric data D90, VlOO, V150 and V200 for forty-six patients of both 
techniques.
Patients Intra-operative Virtual
D90 VlOO V I50 V200 D90 VlOO V I50 V:
1 180 76 99 93 5738 2537 160.75 9445 4831 2230
2 179.25 9&8 5&42 2335 138.23 8734 3844 16.21
3 171.65 99 67 5735 2535 155.89 92.92 48.41 19.97
4 17332 99 98 5740 26 96 157.82 9338 5032 20.61
5 166 83 99 86 56 95 2648 168.13 97.99 5339 23 33
6 172.12 99 94 56.17 24.42 139.75 8835 5138 2241
7 174.47 100 57.54 2244 156.97 93.43 4636 19.20
8 176.92 99.67 5537 1836 162.81 95.39 47.40 15.74
9 179.87 9937 5733 2536 163.95 97.12 4832 19.07
10 177.65 9931 61.50 2638 169.07 96.25 5249 2066
11 180 39 100 58.71 2332 161.36 95.24 44.07 18.97
12 172.49 99 56 59.90 25 34 166.29 9835 5236 23 36
13 180 83 99.00 6433 27.61 156.91 92.99 50.05 2135
14 171.75 99 99 5937 27.19 166.20 98.47 51.79 2238
15 176.44 9937 59.44 2032 163.52 94.46 4538 14.02
16 178.56 9976 58.41 23 34 172.45 97.31 49.92 19.00
17 180.92 98 69 5937 2533 171.67 98.00 4543 18.75
18 175 96 9933 5739 25.14 13349 88.05 41.72 18.22
19 171.37 99.81 6032 2735 164.58 98.40 55.37 23.49
20 174.70 9&95 57.51 2333 167.59 9739 50.79 18.29
21 175.61 99 76 5832 2537 130.91 87.00 43.43 19.66
22 174.95 9934 55.91 20.42 170.45 99.54 49.75 15.50
23 159.43 9838 40.94 15.59 159.44 95.11 4232 12.33
24 171.32 99 96 5830 27.11 140.25 89.14 46.00 19.95
25 179.70 9933 56.67 21.46 173.57 9 8 M 42.29 19.50
26 167.63 9931 6037 2639 171.02 97.98 5438 20.55
27 175.96 9932 5831 2539 116.43 8230 40.10 17.36
28 172.23 (#39 60.42 25.61 107.40 79.17 42.09 18.95
29 175.22 100 58.16 2435 164.52 95 88 5066 21.16
30 177.47 9939 5937 23.12 170.93 99 62 5237 19.65
31 173.54 9936 5532 23.19 163.14 9533 5037 20.54
32 174.70 99.67 61.78 28.33 15630 9349 4839 19.48
33 173.31 99.77 56.71 25.68 157.29 9237 4538 18.33
34 170.84 99 86 6238 27.20 162.93 95.45 49 66 17.91
35 17Z88 100 60.05 29.95 165.56 96.44 46.94 16.43
36 174.07 99.99 6339 3035 153.49 9238 5037 21.58
37 178.21 9392 5834 22.48 171.69 9933 4932 18.54
38 172.40 9337 5543 22 91 160.23 9439 50.63 21.34
39 173.62 99.31 5736 2Z94 168.20 9542 4538 17.90
40 186.11 93.42 6534 28.79 143.00 8942 42.51 16 63
41 179.15 93.82 57.13 23.21 152.61 9135 44.70 17.20
42 173.31 93.82 57.02 24.74 153.53 94.48 3734 16.61
43 175.29 99.95 61.79 26.31 15833 9330 50.19 20.41
44 178.82 93 99 5933 23.28 161.83 9237 46.46 18.20
45 167.59 99.81 4936 2258 15238 9139 48.01 2038
46 174.36 93 95 5737 2435 16639 9926 52 65 2133
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These differences result from using a minimum seed spacing of 0.5 cm in the present 
study (Mick applicator placement) whereas the Wilkinson et al. (2000) study using 
Model 7000 Rapidstrand ' seeds were limited to a minimum of 1.0 cm seed spacing.
Table 5. The averages of the parameters V200, V I50, VlOO and D90.
Parameters(Ave) Intra-operative(n=46) Virtual(n=46)
V200(%)
V150(%)
V100(%)
D90(Gy)
24.8±2.78
58.3±3.74
99.7±0.38
174.9±4.5
19.23=2.42
47.93=4.16
94.1±4.41
157.6±14.4
The Mick applicator allows the placement of individual seeds in an end to end
arrangement as the plan dictates whereas Rapidstrand’̂” seeds are in fixed seed-spacer
seed arrangement at 1.0 cm spacing.
Table 6. Comparison of VlOO, V150, and D90 intra-operative values with Wilkinson et 
id. (2000)
V100(%) V150(%) D90 (Gy)
Wilkinson et al. study 
n = 61 
Our study
n = 46
98.5±1.9 22.5±9.8 
99.7±0.38 58.3±3.74
136.5Ü8.8
174.9±4.5
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3.3 Post Seed Implant Analysis 
Evaluation o f the intra-operative plan is based on CT images obtained three to four 
weeks following the implant procedure. The average post implant dosimetric parameters 
shown in Table 7 are approximately 6% lower than those values obtained intra- 
operatively for V150 (55.7% vs. 58.3%) and VlOO (94.1% vs. 99.7), while a 8% lower 
mean value is noted in the post implant analysis for D90 (161.5 Gy vs. 174.9Gy). The 
prostate volume on the post implant CT is slightly larger for all forty-six patients 
compared to the intra-operative planned cases because CT images tend to over estimate 
prostate volume compared to ultrasound. Due to the similar density of prostate tissue and 
surrounding periprostatic tissue on CT images, the prostatic capsule is more difficult to 
define on CT than on ultrasound. Also the amount of swelling depends on the trauma of 
the implantation procedure (Wilkinson et al. 2000).
Table 7. Comparison of the average values V I50, VlOO, D90 and the average prostate 
volume between post seed implant and intra-operative and virtual-techniques.
Parameters Post Seed Implant Intra-operative Virtual
V I50(%) 55.7±10.6 58.5±2.44 48.3±3.10
VlOO(%) 94.U4.64 99.73=0.29 94.73=2.75
D90 (Gy) 161.53=14.7 173.23=5.11 158.23=9.46
Volume (cc) 44.63:12.7 42.96±13.0 43.53=12.1
Placement of seeds by the radiation oncologist typically follows a concave pattern 
around the lateral and posterior aspects of the prostate. The effect this seed placement has 
on rectal dose can be evaluated by measuring RlOO, the rectal volume that receives 100%
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of the prescribed dose. The distribution of RlOO values obtained from an analysis o f post­
implant CT images is shown in Table 8. Waterman et al. (2003) indicates that the volume 
threshold for risk o f developing Grade 2 (ulceration) late rectal morbidity (modified 
Radiation Therapy Oncology Group grading system) at 100 Gy, 160 Gy and 200 Gy is 
3.8 cc, 1.8 cc, and 0.9 cc, respectively. Based on these data, our result of rectal volume 
threshold for risk o f developing Grade 2 at 145 Gy is 2.3 cc.
Table 8. RlOO (the rectal volume that receives 100% of the prescribed dose) data 
distribution for forty-six patients.
RlOO (cc) Number of Patients (n=46)
0-0.5 21
0.5-l.G 13
1.0-1.7 11
1.7-2.3 0
>2.3 1
Table 8 shows that 1 case is greater than the volume threshold, 2.3 cc. This patient 
has not had serious rectal complications; however, the follow up time is short and close 
observation should be continued for 3 to 5 years. RlOO overestimation can either be the 
result of incorrectly contouring the prostate-rectum boundary, which can be difficult to 
distinguish from mid gland to the apex, or the result of rectum deformation from a large 
amount of gas in the rectum.
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CH APTER 4 
CONCLUSION
In this study the dosimetric evaluations of intra-operative and virtual-implant 
techniques based on the dose volume histogram (DVH) generated from CT studies were 
analyzed. The investigation was made of intra-operative and virtual-planning parameters 
(D90, VlOO, V I50 and V200) utilizing post implant dosimetry. The parameters given in 
Table 5 shows that greater dosimetric values are noted in the intra-operative technique vs. 
virtual-planning technique for D90 (174.9 Gy vs. 157.6 Gy), VlOO (99.7% vs. 94.1%), 
V I50 (58.3% vs. 47.9%) and V200 (24.7% vs. 19.2). Additionally, a study of RlOO 
(Table 8) was performed and an analysis was made of other parameters such as the 
number of images, seeds, target volume (Table 2), and the inferior extent of posterior 
planes, given in Table 3.
Even though the average number of seeds placed within the gland is similar (93 vs. 
92) between the intra-operative and virtual-techniques, the percentage of patients with 
seeds outside the PTV differed significantly for each technique as can be seen in Table 9. 
In Table 9, 70% of the virtual-planning patients would have had more than 5 seeds and 
30% more than 10 seeds placed inferior o f the PTV indicating possible rectal 
complications, leading to rectal morbidity if the pre-planning technique were utilized 
without any adjustment.
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Table 9. Percentage o f Patients with Seeds outside the PTV in the Virtual-technique and 
Intra-operative Technique
Seeds outside the Percentage of Patients
PTV Virtual Intra-operative
Inferior ( ^ ) 70 0
Inferior ( ^  0) 30 0
Lateral/Anterior ( ^ ) 67 2
Lateral/Anterior ( ̂  0) 33 0
Additionally, 67% of the virtual-planning patients would have had more than 5 seeds 
placed lateral/anterior of the PTV and 33% more than 10 seeds resulting in lower 
dosimetric values of parameters given in Table 5. On the other hand, in the intra- 
operative technique no patients had more than 5 seeds placed inferior o f the PTV, and 
only one patient (2%) had more than 5 (6) seeds placed lateral/anterior o f the PTV. 
Within the present limited study of forty-six patients no rectal complications or morbidity 
have developed. Late injury to the rectum usually occurs in the first 2-3 years after 
treatment (Eiffel et al. 1995). Because the seed implants occurred between 2002 and 
2004, it is too early to detect potential rectal complications within these patients.
This study shows the importance o f several factors that benefit from an intra- 
operative approach to seed placement as opposed to a pre-planned approach. The first 
benefit is the obvious elimination of the discomfort of catheter insertion (to accurately 
define the urethra location within the prostate) while the patient is sedated, as opposed to 
the unsedated approach used during the pre-planned technique. Second, accurately 
defining the inferior extent of seeds placed in the most posterior aspect o f the prostate 
reduces the probability for rectal complication and morbidity. Third, more correctly
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delineating the prostate contour at the time of seed placement results in fewer seeds 
placed in the periprostatic region, outside the PTV, both reducing potential seed 
migration and increasing prostate dose coverage. The significance of the increase in dose 
coverage for the intra-operative technique, which varied over the virtual-technique 29% 
in the V200, 22% in the V I50 and 6% in the VlOO values, requires future analysis. It 
appears to be due to shape differences (as opposed to volume differences) between the 
pre-planned (unsedated) prostate and the intra-operative (under general anesthesia) 
prostate. The increase in this study in the dosimetric values o f V150 and V200 appears to 
be related to the technique o f placing seeds at 0.5 cm spacing (as indicated by the 
differences with the Wilkinson et al. data). Additionally, analysis of seed placement 
shows that 66 % of the seeds, both peripherally and interiorly, were spaced at 0.5 cm. The 
influence on patient survival and/or morbidity of the relationship o f dose coverage and 
seed separation requires a study with a larger patient population and a longer follow-up.
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